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Introduction
Mammary gland development during the pregnancy cycle
is characterized by successive phases of cell growth, dif-
ferentiation, high metabolic activity and apoptosis. At the
ultrastructural level this includes dramatic changes in
tissue architecture, involving ductal epithelial branching
and morphogenesis, invasion of tissue compartments, vas-
cularization and subsequent organized remodelling. These
events are highly reproducible and strictly controlled at the
transcriptional level by circulating hormones and locally
derived factors [1]. Thus, many transcription factors have
been shown either to directly affect this developmental
program or to exhibit altered activity at specific stages in
the pregnancy cycle [1].
CAM = cell adhesion molecule; C/ebp = CAAT-enhancer binding protein; IGF = insulin-like growth factor; IL = interleukin; LIF = leukaemia
inhibitory factor; LPS = lipopolysaccharide; NF-κB = nuclear factor-κB; Stat = signal transducer and activator of transcription.
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Abstract
Introduction In order to gain a better understanding of the
molecular processes that underlie apoptosis and tissue
regression in mammary gland, we undertook a large-scale
analysis of transcriptional changes during the mouse mammary
pregnancy cycle, with emphasis on the transition from lactation
to involution.
Method Affymetrix microarrays, representing 8618 genes,
were used to compare mammary tissue from 12 time points
(one virgin, three gestation, three lactation and five involution
stages). Six animals were used for each time point. Common
patterns of gene expression across all time points were
identified and related to biological function.
Results The majority of significantly induced genes in
involution were also differentially regulated at earlier stages in
the pregnancy cycle. This included a marked increase in
inflammatory mediators during involution and at parturition,
which correlated with leukaemia inhibitory factor–Stat3 (signal
transducer and activator of signalling-3) signalling. Before
involution, expected increases in cell proliferation, biosynthesis
and metabolism-related genes were observed. During
involution, the first 24 hours after weaning was characterized
by a transient increase in expression of components of the
death receptor pathways of apoptosis, inflammatory cytokines
and acute phase response genes. After 24 hours, regulators of
intrinsic apoptosis were induced in conjunction with markers of
phagocyte activity, matrix proteases, suppressors of
neutrophils and soluble components of specific and innate
immunity.
Conclusion We provide a resource of mouse mammary gene
expression data for download or online analysis. Here we
highlight the sequential induction of distinct apoptosis pathways
in involution and the stimulation of immunomodulatory signals,
which probably suppress the potentially damaging effects of a
cellular inflammatory response while maintaining an appropriate
antimicrobial and phagocytic environment.
Keywords: apoptosis, immunity, involution, mammary, microarray
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Our laboratory has focused on the role of transcription
factors in postlactational regression of the gland after
weaning. Involution can be divided into at least two
phases [2–4], broadly comprising the following: an initial
reversible phase whereby the gland maintains its gross
morphology but undergoes a substantial increase in the
rate of epithelial cell apoptosis [5]; and a secondary irre-
versible phase, which involves the destruction of base-
ment membrane by matrix metalloproteinases, phagocytic
clearance of milk, and apoptotic bodies and alveolar col-
lapse [6]. Immune cells are present at all stages of
mammary development, including involution [7], but the
precise role of the immune system during postlactational
regression has yet to be fully established. Many genes
have been shown to be differentially regulated during invo-
lution [5,8,9]. However, there has been no comprehensive
analysis of gene expression in mammary involution.
Microarray analysis has had a major impact on our under-
standing of the transcriptional basis of complex biological
systems. Normal tissue development and homeostasis has
been studied in a variety of mouse tissues, including retina
[10], liver [11], pancreas [12], uterus [13] and mammary
gland [14].
The few microarray studies of normal mouse mammary
gland described in the literature have either focused on
early stages in the developmental cycle [14], or have used
mammary data as a tool for illustrating methods of data
analysis [15,16].
In the present study we applied a microarray approach to
study the transcriptional expression (mRNA levels) of
8618 mouse genes in mammary gland during the preg-
nancy cycle. We focused on five time points in involution
but we also included earlier time points in the pregnancy
cycle to establish the specificity of these involution-related
genetic changes. We provide the raw microarray data files
and processed genelists for online analysis or download
(see the Mammary Apoptosis and Development Group
Home Page: www.path.cam.ac.uk/~madgroup). Here we
highlight specific aspects of the microarray data that are
pertinent to involution by identifying common patterns of
gene expression and relating them to specific biological
functions. Thus, we demonstrate the sequential activation
of death receptor genes followed by components of the
mitochondrial (intrinsic) pathway after weaning, suggest-
ing that different apoptosis mechanisms are employed at
different phases of involution. We also highlight a promi-
nent role for immune related genes in involution, equating
this with phagocytic clearance of apoptotic cells and the
maintenance of an antimicrobial environment during milk
stasis. We provide evidence that the proapoptotic, acute
phase transcription factor Stat3 (signal transducer and
activator of transcription-3) [17,18] may simultaneously
suppress a potentially damaging cellular infiltrate. A similar
study conducted in Balb/c mice and described in the
accompanying paper in this issue [19] confirms proinflam-
matory gene expression in involution. Together, these data
provide a useful online resource for studying the activity of
specific genes in mammary involution.
Method
Mouse husbandry
Six-week-old C57/Bl/6 mice were obtained from Harlan
Laboratories (Bicester, UK). At 8 weeks females were
either mated or culled for virgin mammary glands. Postpar-
tum, a minimum of six pups per suckling female was
ensured by cross-fostering where appropriate. Females
used in involution time points were force weaned at
10 days of lactation. Lactating and involuting mammary
glands were monitored daily for signs of localized inflam-
mation or mastitis. Two out of 90 animals were excluded
from the study for this reason. The study was approved by
the local ethics committee and complies with the Helsinki
Declaration.
Harvesting mammary gland RNA
A total of 12 stages of adult mouse mammary gland devel-
opment were selected for this study: 8-week-old virgin;
5 days, 10 days and 15 days of gestation (in which day 1
was the first day postcoitum); 0 days (first day post-
partum), 5 days and 10 days of lactation; and 12, 24, 48,
72 and 96 hours after forced weaning. All mammary
glands were harvested between 11:00 and 13:00 to limit
circadian effects. A total of six animals were used per time
point (three per hybridization). In each case a single
abdominal gland was removed following excision of lymph
nodes and immediately frozen in liquid nitrogen. RNA was
extracted from frozen tissue using Trizol reagent (Invitro-
gen, Paisley, UK) followed by additional column purifica-
tion (Rneasy; Qiagen, Crawley, UK). Briefly, three samples
of mammary tissue from the same time point were ground
under liquid nitrogen, and 20 mg of each was pooled into
1.5 ml Trizol reagent. Resuspended RNA samples were
then passed through purification columns according to the
manufacturer’s instructions and RNA integrity was moni-
tored with Lab-on-a-chip (Agilent, West Lothian, UK)
before use in microarray analysis.
Microarray hybridization and data analysis
RNA 5 µg was labelled according to manufacturers proto-
cols (Affymetrix, High Wycombe, UK) and hybridized to
Affymetrix MGU74ver2a chips representing 12 488 tran-
scripts or 8618 genes. Computation of expression values
was performed using the perfect match/mismatch model
implemented in dChip [20].
Twenty-four Affymetrix hybridisations (two for each
mammary time point) were selected following removal of
outliers identified by dChip. All subsequent analyses were
performed with Genespring analysis software (Silicon
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Genetics, Redwood City, CA, USA). Two filters were
applied to the complete data set of 12 488 transcripts.
First, 755 transcripts (6%) were removed following elimi-
nation of genes whose mean signal intensities were below
20 normalized intensity units in at least 11 of the 12 time
point conditions. Second, 5149 transcripts (44%) were
removed on the basis that they exhibited no significant
change in mean signal intensity across all time points
(Welch ANOVA P = 0.05, using the Benjamini and
Hochberg False Discovery Rate controlling procedure). A
separate lactation/involution specific time course gene set
was established by applying the same cutoff filters to all
12 488 transcripts using 5 day and 10 day lactation time
points, and 12, 24, 48, 72 and 96 hour involution time
points.
Both data sets were clustered (K means) according to
expression pattern similarity across all 12 conditions (com-
plete time course) or seven conditions (involution time
course) using standard correlation. Nine K mean classifi-
cations were performed for each data set, starting with
10 clusters and increasing by five incrementally to 50 clus-
ters. The optimal number of clusters was determined
empirically based on highest observed variability and
redundancy between similar clusters.
All genes were annotated according to known function
using the Gene Ontology Consortium categories [21]: bio-
logical process, cellular component and molecular function.
Onto-Express [22] was used to determine whether clusters
of genes with similar expression profiles were enriched in
specific GO functional categories. Based on the genes
present on the GeneChip, Onto-Express calculated the
expected number of occurrences of each functional cate-
gory in each cluster. The probability that each functional
category was over-represented in a cluster was derived
using a binomial model and the P values were corrected for
multiplicity using the Bonferroni method. Thus, Onto-
Express provided information about the statistical signifi-
cance of each of the pathways and categories represented
by the genes in each cluster (these data are available
online as Additional files 1 and 2).
Archived data
All genelists, including expression profile clusters, ontolog-
ical definitions and all raw data .cel files, fulfilling MIAME
criteria, were uploaded to ArrayExpress (http://www.ebi.
ac.uk/arrayexpress/) and are also available through GeNet
(http://genet.hgmp.mrc.ac.uk:8080/servlet/GeNet) for down-
load and online analysis. (For information on accessing
data through GeNet or from Breast Cancer Research see
our website: www.path.cam.ac.uk/~madgroup/). Gene
lists use Affymetrix probe_ID and accession number as
transcript identifiers. In the body of the text and figures,
gene/transcripts are named according to the Mouse
Genome Database [23].
Results
We analyzed the expression of over 12 000 transcripts, or
approximately one-third of the protein encoding capacity
of the mouse genome, at 12 different time points in the
mammary gland pregnancy cycle. We focused our analy-
sis on the changes in gene expression that occur during
the first 4 days of postlactational regression, harvesting at
five time points during this period. We also included three
time points in lactation, three in gestation and a single time
point in nulliparous animals in order to distinguish
between involution-specific genes and genes that were
also highly expressed at other times in the pregnancy
cycle. All raw and normalized data files were submitted to
GeNet and made available for download or online analysis
through our website (www.path.cam.ac.uk/~madgroup/).
Expression of 6796 transcripts (54% of the transcripts
assayed) significantly changed across the 12-point time
course. This suggested that approximately half of the
protein encoding content of the mouse genome was regu-
lated in mammary gland at some point during the preg-
nancy cycle. Among the genes that did not significantly
change (nonsignificant profiles genelist in GeNet) were a
number of recognized ‘housekeeping’ genes, including
18s ribosomal and α-actin genes. However, other genes
that are ubiquitously expressed in some cell types (e.g.
GAPDH and cyclophilins) exhibited differential expression
in the mammary time course. This reflects a combination
of factors, including changes in tissue composition and
dramatic shifts in cellular metabolism and macromolecular
synthesis throughout the mammary cycle, in particular
during lactation.
In order to verify that the microarray time course reflected
expected global expression patterns in vivo, we compared
our results with the known mammary expression patterns of
32 genes described in the literature, all of which exhibited
the expected expression profiles (see Additional file 3).
Expression profile analysis of the pregnancy cycle
(12-point time course)
It was expected that a proportion of the 6797 differentially
expressed transcripts would be specific to involution,
whereas others may have additional roles at earlier stages
in the pregnancy cycle. In order to identify these subsets
of involution related genes, the expression patterns of all
differentially expressed transcripts were compared and
subsequently grouped according to similarity into 35 gene
profile clusters. Some clusters exhibited superficially
similar patterns (Fig. 1). In order to simplify the classifica-
tion of expression patterns observed in the time course,
these similar profiles were pooled, resulting in 11 broadly
distinct expression profiles (Fig. 1a).
These 11 clusters represented maximal gene expression
at different stages during the pregnancy cycle. Thus, one
cluster of 651 transcripts (5% of all transcripts on the
array) were maximally expressed in virgin mammary gland
(VSL). Two clusters with a total of 2317 transcripts (19%)
were maximally expressed in gestation (G and GSL) and
three clusters (529 transcripts, 4%) were maximally
induced during lactation (LT, L and LG). Four clusters
(3113 transcripts, 25%) exhibited maximum expression
during involution (IL, IT, IP and IG) whereas one cluster
Available online http://breast-cancer-research.com/content/6/2/R92
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Figure 1
Clusters of gene expression profiles from a 12-point time course of adult mammary gland development. Thirty-five K means clusters were obtained
from 6796 differentially expressed genes across a 12-point time course of the adult mammary gland pregnancy cycle. In order to identify basic
trends in expression, these clusters were arbitrarily organized into groups based on the similarity between their mean profiles (b). These clusters
were pooled and displayed as combined average expression profiles (a). (a) Combined expression profiles named according to developmental
stage exhibiting maximal expression (capital) and their associated expression pattern (subscript). VSL, virgin and suppressed lactation; G, gestation;
GSL, gestation and suppressed lactation; LT, lactation, transient; L, lactation; LG, lactation and gestation; IL, involution and lactation; IT, involution,
transient; IP, involution and parturition; IG, involution and gestation; PC, postcoitum. Y axis is the mean normalized signal intensity. Dotted lines
indicate boundaries between major phases of development: virgin to gestation; parturition; and 10-day lactation (forced weaning). Total number of
genes in each combined cluster shown to the right. (b) Thirty-five K means clusters. Total number of genes (brackets) and the ID for each cluster is
shown. Each differentially expressed transcript is represented only once in the 35 clusters. Error bars represent standard error of the mean. X axis
is the 12 developmental time points used in microarray analysis: v, virgin (8 week); G, gestation (days 5, 10 and 15 postcoitum); L, lactation (days
0, 5 and 10 postpartum); I, involution (days 0.5, 1, 2, 3 and 4 after forced weaning).
included 187 transcripts (1%) that were uniformly
expressed throughout the pregnancy cycle (PC). Further
details on the nomenclature of these combined clusters
are provided in the legend to Fig. 1. Genelists for each
combined cluster and the 35 primary clusters are available
online (see Method section, above).
Six clusters consisted of transcripts that were either maxi-
mally expressed during involution (IL, IT, IP and IG) or
specifically suppressed following weaning (L and LG), sug-
gesting that a proportion of these genes may play impor-
tant roles in regression of the mammary gland. These six
clusters consisted of 3463 transcripts, or 28% of all tran-
scripts on the array. Only one group of 518 genes exhib-
ited involution-specific expression, all of which were
transiently activated within 24 hours after weaning (IT). It
was expected that a proportion of these represent genes
that may contribute to the initial phase of cell death char-
acteristic of the reversible first stage of involution. All other
involution related clusters exhibited elevated expression at
earlier stages in the pregnancy cycle. For example, one
group of 236 involution related genes (IP) exhibited an
additional peak of expression specifically at parturition.
This suggested that many transcriptionally regulated
processes in involution were common to gestation (IG),
parturition (IP) or lactation (IL).
Correlation of gene function with gene expression
pattern
Of the 6747 differentially expressed transcripts, 3273
(49%) encoded proteins with known function. In order to
establish what proportion of the transcripts in each cluster
from Fig. 1a shared common biological functions, tran-
scripts with known function were assigned to categories
as defined by the Gene Ontology Consortium
(www.geneontology.org), and statistically significant asso-
ciations between gene function and each cluster were
identified using Onto-Express [22]. The significant associ-
ations (corrected P < 0.05) are listed in Table 1. Further
details on the distribution of functionally related genes
between these clusters are available in Additional file 4.
Unexpectedly, similar proportions of apoptosis related
genes were expressed in each of the 11 clusters; the only
significant correlation being with the IL cluster, in which
maximal gene expression occurred at 12 hours of involu-
tion. However, a number of other biological processes
were significantly linked to particular stages of mammary
development, and were consistent with our current under-
standing of the physiology of the mammary gland. Thus,
during gestation there was a significant increase in the
expression of cell cycle regulatory genes (G, GSL and IG)
and a concomitant increase in nucleic acid and macromol-
ecular synthesis (‘biogenesis’ and ‘metabolism’ in
Table 1). By lactation, the proportion of cell cycle genes
had diminished, to be replaced by an increase in the
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Table 1
Relationship between gene expression pattern and gene
function in the 12-point developmental time course
Biological Molecular
Cluster Transcripts process function
VSL 357 Metabolism Immunity
Cell surface signal Signal transducer
Development
ECM and morphogenesis
G 349 Cell cycle Cell cycle
Cell growth Cytokine
GSL 605 Biogenesis Cancer
Cell cycle Enzyme
Nucleic acid
Chemokine
LT 35 Cell adhesion Signal transducer
Metabolism Transport
Transport Cytokine
Cell surface signal
Intracellular signal
L 144 Biogenesis Cancer
Metabolism Transport
Transport
Development
ECM and morphogenesis
LG 83 Cell cycle Enzyme
Metabolism
Development
Physiological process
ECM and morphogenesis
IL 624 Cell death Apoptosis
Metabolism Immunity
Transport Signal transducer
Development Transport
ECM and morphogenesis
IT 245 Biogenesis Signal transducer
Cell cycle
Cell growth
Cell surface signal
Intracellular signal
IP 156 Biogenesis Immunity
Homeostasis Signal transducer
Transport Transport
Intracellular signal
IG 582 Cell cycle Cell cycle
Metabolism Transport
Proliferation
Transport
PC 93 Transport Transport
ECM and morphogenesis
Transcripts representing genes with known function were classified by
molecular function and biological process, according to the ontological
definitions of the Gene Ontology Consortium. The total numbers of
known transcripts classified in this way are shown for each cluster. A
statistical test for nonrandom distribution of these functional groups
(taking into account the total number of transcripts in each category)
was performed on each cluster using Onto-Express. All statistically
significant associations (corrected P < 0.05) are listed for each cluster
using broad ontological definitions. The genes making up these broad
categories are provided on GeNet (see Method section). Additional
information on the details of these significant associations and a
graphical representation of all ontologies are available as Additional
files 1 and 4. ECM, extracellular matrix.
number of genes involved in development and differenti-
ated function, including fatty acid biosynthesis and other
metabolic processes (LG, L and IL). These three clusters
should therefore contain genes that are important for ter-
minal differentiation and transition to a secretory pheno-
type (genelists for each cluster are available online; see
Method section, above).
Morphogenesis and tissue remodelling are characteristic
features of the mammary gland both during pregnancy
and late in postlactational regression. We observed sig-
nificant correlations between morphogenesis and three
clusters with broadly similar expression profiles (LG, L and
IL), each being characterized by increased gene expres-
sion during gestation and lactation followed by a marked
and progressive decline at the lactation–involution
boundary. A significant proportion of remodelling-related
genes were also observed in the VSL cluster, which exhib-
ited an inverse pattern to the three profiles described
above. Because the transcripts in the VSL cluster were, by
definition, distinct from those in the LG, L and IL groups, it
is possible that the former may contain remodelling
related genes that contribute to mammary regression
whereas the latter group of three clusters contains genes
that are involved in invasion and remodelling of the fat
pad during pregnancy.
The major differences between these two groups of genes
were the high number of cell adhesion molecules (CAMs;
e.g. Ceacam-10 and -11, integrins α5 and β3, Vcam1,
Ncam1, Pecam and Cadherin-8) and bone morphogenic
protein (Bmp5 and Bmp7) genes in clusters LG, L and IL
compared with the relatively high proportion of matrix com-
ponents (e.g. laminin-α2, -α4 and -β2; procollagen types
Iα1, Iα2, IVα1, IVα2, Vα1, VIα1, VIα2, VIα3, XIVα1 and
XV; fibronectin-1 and decorin), matrix metalloproteinases
and inhibitors (Mmp9, Mmp14, Timp3) and fibroblast
growth factors (Fgf1, Fgf2) in the VSL cluster.
A strong statistical relationship existed between involu-
tion and immune-related genes (Table 1 and Fig. 2). Of
the four clusters exhibiting maximal gene expression
during involution, three were significantly associated
with inflammation (IT), the acute phase response (IP and
IL), or humoral immunity (IP). Of the remaining eight clus-
ters, VSL, whose transcripts exhibited a modest increase
during involution (and were linked with remodelling),
was associated with innate cellular defence (Fig. 2).
Immune genes were most prevalent in the IP cluster, in
which transcripts were transiently expressed at parturi-
tion and maximally expressed by 48 hours of involution
(Fig. 2). Of the 57 immune-related genes present in the
IP cluster (24% of known genes in the cluster), 43
(18%) were immunoglobulin genes, seven (3%) were
acute phase protein genes and seven (3%) were inflam-
matory mediators.
Acute phase gene expression correlates with Stat3 activity
We have previously shown that the IL-6 family cytokine
leukaemia inhibitory factor (LIF) induced phosphorylation
(and activation) of Stat3 in mammary gland during involu-
tion, and that this transcriptional signalling pathway was
important for the induction of apoptosis in the early involut-
ing gland [17,24]. Stat3 is also a recognised mediator of
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Figure 2
Relative expression of immune related genes in the 12-point timecourse
of mammary development. Immune-related transcripts differentially
expressed in the 12-point developmental time course were grouped
into five categories that represent different immunological functions. The
number of transcripts in each category is shown in brackets. Genelists
of all transcripts assigned to these immunological categories are
available online. (a) The frequency of transcripts in each expression
profile cluster for each immunological category. Statistically significant
associations, as determined by Onto-Express, are indicated with
asterisks. Y axes indicate the percentage for each cluster. X axis
indicates the combined expression profile clusters. (b) The mean
expression profiles for all transcripts in each immunological category.
Y axis indicates the mean normalized signal intensity, and the X axis
indicates the 12 developmental time points (see Fig.1).
the acute phase response, and because acute phase
related genes exhibited a parturition/involution expression
profile (Fig. 2) we assessed the relationship between
Stat3 activity and acute phase gene expression.
Acute phase proteins are classified according to the tran-
scriptional signalling pathways that regulate their expres-
sion [25]. Thus, class I acute phase genes are activated
by cooperative binding of CAAT-enhancer binding protein
(C/ebp)β, C/ebpδ and/or nuclear factor (NF)-κB (and in
some cases also Stat3) to specific sites in their promot-
ers. Class II genes are activated by Stat3 alone. Class I
genes were induced at parturition and involution (similar to
the IP profile). Class II genes were transiently, and specifi-
cally, expressed at the onset of involution (similar to the IT
profile). We previously described Stat3 and NF-κB activi-
ties in the mammary pregnancy cycle [24,26], whereas
Cebp gene expression in mammary gland has also been
described [27]. We compared the expression of these
transcription factors and found that Stat3 and both Cebp
genes in addition to phosphorylated Stat3 DNA binding
activity [17] correlated with class I acute phase gene
expression (Fig. 3).
Expression profile analysis of lactation/involution
(seven-point time course)
In order to define patterns of gene expression pertinent to
the lactation–involution transition, irrespective of expres-
sion in pregnancy, differentially expressed genes were
reclustered using a truncated time course involving lacta-
tion and involution time points only (Fig. 4). A total of 4103
transcripts (33% of all transcripts) exhibited significant
changes in expression across the seven time points,
namely 5 days and 10 days of lactation, and 12, 24, 48,
72 and 96 hours of involution. These profiles were sorted
according to similarity into 15 clusters (Fig. 4b). Similar
clusters were then combined to produce seven basic pro-
files that differed according to the kinetics of gene induc-
tion or suppression during lactation and involution
(Fig. 4a). Thus, four patterns of activation were observed:
a rapid but transient increase in gene expression 12 hours
after weaning (Inv1); a rapid activation, which was maximal
by 12 hours and sustained for up to 4 days (Inv2); a
slightly delayed induction, maximal by 24/48 hours, and
sustained for at least 96 hours after weaning; and a
gradual increase in expression, which peaked at or
beyond 96 hours (Inv4). Similarly, three patterns of sup-
pression were observed: a transient decrease in transcript
levels that mirrored the pattern observed in Inv1 (Lac1); a
rapid loss of expression, reaching baseline levels at 12/24
hours and remaining low for up to 96 hours (Lac2); and a
delayed reduction in expression, originating from a peak in
expression at 12 hours involution and reaching a minimum
beyond 96 hours (Lac3).
These patterns inferred three phases of gene expression
during involution: rapid changes within the first 12 hours
(Inv1, Inv2, Lac1, Lac2), delayed expression by
24–48 hours (Inv3), and prolonged changes extending
beyond 4 days (Inv4, Lac3).
Consistent with our analysis of the complete 12-point time
course, we found that involution related gene expression
was associated with an overall increase in immune gene
expression (Table 2 and Fig. 5; also see Additional file 5).
There was an initial transient increase in proinflammatory
genes (Inv1). However, the association was most pro-
nounced with transcripts exhibiting delayed kinetics (Inv4),
in which known genes involved in innate immunity, antimi-
crobial defence and inflammation were all preferentially
expressed. The delayed immunological changes also coin-
cided with a significant increase in apoptosis markers (see
below) and factors that affect tissue architecture, includ-
ing genes encoding structural proteins (decorin, laminins,
Breast Cancer Research    Vol 6 No 2 Clarkson et al.
R98
Figure 3
Mean expression profiles of acute phase genes. (a) Expression profile
of the signal transducer and activator of transcription (Stat)3 transcript
(red), as compared with CAAT-enhancer binding protein (c/ebp)β
(dark blue) and c/ebpδ (light blue) from the microarray. (b) The mean
expression profiles of 12 class I acute phase response genes (cI APR;
red) and five class II acute phase response genes (cII APR; blue). Y
axes indicate mean normalized intensity, and X axes indicate the
developmental time points in days. Error bars represent standard error
of the mean. Gest, gestation; Lac, Lactation; Inv, involution.
Nid1, collagen 1α1, 1α2, 3α1 and 4α2) and matrix asso-
ciated proteins (Mmp3, Mmp12, Gelsolin, uPa and
Adamts1), thus corroborating previous reports of the role
of matrix proteases in remodelling of the regressing
mammary gland [2]. Lactation specific expression, as
expected, was associated with downregulation of differen-
tiation and metabolic processes after weaning (Lac2 and
Lac3; Table 2).
Cytokine expression highlights two immune phases
during involution
In order to gain further insight into the immune responses
associated with mammary involution, we listed the
cytokines, chemokines and immune-related genes associ-
ated with each involution profile from Fig. 4 (Table 3). This
confirmed the two phases of immune-related gene expres-
sion illustrated by Fig. 5: an initial transient expression of
Available online http://breast-cancer-research.com/content/6/2/R92
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Figure 4
Clusters of gene expression profiles from a seven-point time course of mammary lactation and involution. Fifteen K means clusters of 4103
differentially expressed transcripts from seven stages of lactation and involution. Fourteen primary clusters (b) were grouped according to similarity
into (a) seven basic profiles: Inv1, Inv2, Inv3, Inv4, Lac1, Lac2 and Lac3. These similar clusters were pooled and plotted as seven combined
expression profiles. The 15th cluster represented differential expression between 5-day and 10-day lactation only (not shown). The number of
genes for each pooled cluster is indicated to the right of panel A. The number of genes (brackets) and the cluster ID is indicated for each primary
cluster in panel B. Each differentially expressed transcript is represented only once in the 15 primary clusters. The number of genes in each
combined profile (panel A) is the sum of its primary profiles (panel B). Y axis is the mean of normalized intensities. Error bars represent the standard
error of the mean for all transcripts in each cluster. X axis = 7 point timecourse across lactation (Lac) and involution (Inv). Dotted lines highlight
10 day lactation and 24 hour involution timepoints.
proinflammatory cytokines and TNF superfamily genes fol-
lowed by delayed expression of monocyte and lymphoid
chemokines and immunoglobulin genes.
Thus, an initial burst of cytokine and cytokine receptor
expression was observed within 12 hours of forced
weaning (Inv1; Table 3), which included the acute-phase
mediators LIF receptor (Lifr), IL-11 (Il11) and the neu-
trophil chemoattractant Gro1 (Cxcl1), and the proinflam-
matory mediators IL-1a, IL-1b and IL-13 (Il1a, Il1b and
Il13). This was accompanied by a transient decrease in
other cytokine receptors (including Il11r) and an inhibitor
of IL-1 receptor signalling (Il1rn), suggesting that specific
proinflammatory signals may be suppressed at the tran-
scriptional level.
One expected outcome of the transient cytokine expres-
sion was an infiltration of inflammatory cells, in particular,
neutrophils due to the expression of Cxcl1. Analysis of
immune cell specific antigen expression demonstrated a
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Table 2
The relationship between gene expression pattern and gene
function in the seven-point lactation/involution time course
Biological Molecular
Cluster Transcripts process function
Inv1 292 Transport Immunity
Cell surface signal Enzyme
Intracellular signal Structural
Growth factors
Inv2 153 Transport Enzyme
Inv3 336 Biogenesis Apoptosis
Metabolism Enzyme
Development Nucleic acid
Signal transducer
Structural
Inv4 420 Cell adhesion Apoptosis
Cell surface signal Immuntiy
ECM and Enzyme
morphogenesis Signal transducer
Structural
Cytokine
Lac1 374 Intracellular signal
Lac2 163 Biogenesis Enzyme
Metabolism Nucleic acid
Transport Transport
ECM and morphogenesis
Lac3 188 Cell adhesion Signal transducer
Transport Transport
Development Cytokine
Growth factors
Transcripts representing genes with known function were classified by
molecular function and biological process, according to the ontological
definitions of the Gene Ontology Consortium. The total numbers of
known transcripts classified in this way are shown for each cluster. A
statistical test for nonrandom distribution of these functional groups
(taking into account the total number of transcripts in each category)
was performed on each cluster using Onto-Express. All statistically
significant associations (corrected P < 0.05) are listed for each cluster
using the same ontological definitions used in Table 1 and available on
GeNet. Additional information on the details of these significant
associations and a graphical representation of all ontologies are
available as Additional files 2 and 5. ECM, extracellular matrix.
Figure 5
Relative expression of immune related genes in the seven-point time
course of mammary lactation and involution. Immune-related transcripts
that were differentially expressed in the seven-point lactation/involution
time course were grouped into five categories representing different
immunological functions. The number of transcripts in each category is
shown in brackets. Genelists of all transcripts assigned to these
immunological categories are available online. (a) For each category,
the frequency of transcripts in each expression profile cluster was
plotted. Statistically significant associations, as determined by Onto-
Express, are indicated with asterisks. The Y axis indicates the
percentage of each expression profile cluster, and the X axis indicates
the expression profile cluster. (b) The mean combined expression
profiles of transcripts in each immunological category are also shown
(right). The Y axis indicates the mean normalized signal intensity, and
the X axis indicates the seven developmental timepoints from lactation
(L) and involution (I; see Fig. 2).
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Table 3
Identity of immune-related genes in lactation and Involution clusters
Inv1 Inv2 Inv3 Inv4 Lac 1 Lac2 Lac3
Cytokines Lifr Il11ra2 Il12rb1 Osmr Il1rn Il1rl1l Il1r2
Il1a Ltbr Il1r1 Il4ra
Il1b Il10rb Il7r
Il1r2 Csf1r Il11r
Il11 Csf1
Il13
Chemokines Cxcl1 (Gro1) Ccl9 Ccl6
Ccl7
Ccl8
Ccl21a
Cxcl9
Cxcl14
Immune cell Lsp1 Cd80 Cd14 Cd79a
antigens Cd19 Tnfrsf7 (Cd27) Ly86
H2-M1 Cd86
Cd83 Tnfrsf4 (Ox40)
Tnfsf7 (Cd27l) Lrp1 (Cd91)
Tnfrsf9 (Cd137)
Acute phase A2m Hpxn Cebpb Hp Hpxn Orm1
response Serpina1c Orm2 Lcn2 Saa1 Nr3c1
Cebpd Saa2 Serpina3g
Saa3
Saa-ps
Immunoglobulin IgG-3 h-ch Ig variable regn. IgK l-ch (×2) IgM h-ch (×1) Ig l-ch
IgA h-ch IgL l-ch IgM l-ch (×2)
IgA h-ch IgA h-ch (×4)
Ig K l-ch (×14)
Ig L l-ch (×3)
IgG l-ch (×4)
Ig H18
Immunoglobulin- Fcer1g (Fc rec) Axcam Necl1-pending Sema4a Sema4a
related Pigr Ltf Sema4d
Sema4b Igsf8
Sema7a
Complement C1qa C2 H2-Bf C1qr
C3ar1 C3 C1qbp
C9 C4 C2
C2
C1qa
C1qc
Immune related Tnfsf4 (OX40L) E4bp4 Tgfb1 Casp1 Lig1 Irak1 Tnfaip2
Tnfsf6 (FasL) Inhbb Tgfb3 H2-Aa Traf6
Tnfsf7 (Cd70) Pafah1b2 Tnfrsf6 (Fas) Tnfrsf11a
Tnfsf10 Myd88
Tnfsf12 (Tweak) Emr1
Tnfrsf9 (Cd137) Ecgf1
Il4i1 Pla2g2a
Gp5 Fadd
The identity of immune-related transcripts was determined for each of the combined profile clusters illustrated in Fig. 4. Thus, transcripts belonging
to the ontological category Immunity from each cluster were listed according to the immunological subcategories shown in the first column of the
table. All gene names conform to the mouse genome informatics database [23], synonyms are included in brackets where appropriate. The number
of transcripts of the same immunoglobulin chain genes are indicated. Complete genelists for these immunological categories are available on
GeNet (see Method section).
marked increase in the monocyte/macrophage markers
Lrp, Csf1r and Cd14 (Table 3 and Fig. 6a), but no evi-
dence for an accompanying increase in neutrophils or
eosinophils (polymorphonuclear leucocyte markers Fut4,
Fcgr3, Caecam1, Il8rb and Tnfrsf5 were not induced
during involution; data not shown). This is consistent with
previous observations of the immune cell complement in
regressing murine mammary gland [28] and supports the
hypothesis that neutrophil numbers are suppressed in
involuting tissues in order to prevent subsequent tissue
damage [28,29]. Interestingly, the gene for oncostatin M
receptor (Osmr) was upregulated in involution (Fig. 6b). In
models of inflammation oncostatin M is produced locally
to prevent proinflammatory cytokines such as IL-8 from
recruiting neutrophils, thus attenuating the inflammatory
response [30]. We also confirm a previous report that ute-
rocalin (Lcn2) and Sgp2, a subunit of clusterin, are upreg-
ulated during involution and parturition [19], because their
expression correlates with the IP profile (Fig. 6b). Utero-
calin, an acute-phase response gene that is regulated by
Stat3 [31,32], prevents neutrophil accumulation possibly
through targeted destruction of neutrophils [29], whereas
clusterin protects cells from the damaging effects of neu-
trophils [33,34]. Furthermore, secretory leukocyte pro-
tease inhibitor (Slpi), a potent inhibitor of neutrophil
proteases [35], and a Stat3-induced gene (Boland M and
coworkers, unpublished data) was also markedly upregu-
lated during involution (Fig. 6b). Thus, although the tran-
scriptional effects of the acute-phase mediators LIF–Stat3
and C/ebpβ/δ are clearly evident (Fig. 3), the immunologi-
cal outcome at the cellular level is likely to be minimised by
coexpression of anti-inflammatory factors such as these.
Following the initial ‘spike’ in inflammatory cytokine expres-
sion, six different chemokine genes were slowly induced
over the 4-day period of involution (Inv4; Table 3). These
included chemoattractants for monocytes and
macrophages (Ccl6, Ccl7, Ccl8 and Cxcl14) and lympho-
cytes (Ccl6, Ccl21a, Cxcl9 and Cxcl14). This chemokine
induction was accompanied by a marked increase in
immunoglobulin gene expression (Fig. 5, Table 3). Consis-
tent with these observations, the monocyte/macrophage
markers Lrp1, Csf1r and Cd14, and the lymphocyte anti-
gens Tnfrsf9, H2-M1 and Tnfrsf4 were increased during
involution (Table 3 and Fig. 6a).
Soluble innate defence factors are induced in involution
In addition to the immunoglobulins, genes that encode a
number of innate soluble defence factors were highly
expressed in involution (Table 3 and Fig.6c). These soluble
factors possess antimicrobial properties that are secreted
to protect against mastitis during the vulnerable period of
milk stasis [36]. Thus, the iron chelator lactoferrin (Ltf),
which is found at high levels in the milk of humans and
cattle [37,38], is induced with kinetics similar to those of
the antibody transcripts described above (Fig.5). Comple-
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Figure 6
Involution related expression profiles: apoptosis and immune related
genes. (a) Expression profiles of differentially expressed immune cell
antigens, illustrating the relative proportions of immune cell subtypes in
mammary gland during the complete pregnancy cycle.
Monocyte/macrophage markers: Lrp1=Cd91; Csf1r=Cd115.
Lymphocyte markers: Tnfrsf9 = Cd137; H2-M1 = Mb1;
Tnfrsf4 = OX40. (b) Profiles of differentially expressed anti-
inflammatory factors in the complete mammary time course. (c) Profiles
of differentially expressed soluble defence factors, including the innate
components lactoferrin (Ltf), Cd14, Ly86 and Lbp. Also shown is the
mean expression profile for all differentially expressed immunoglobulin
transcripts. (d) Differentially expressed death receptor ligands
(Tnfsf6 = FasL, Tnfsf12 = Tweak, TNFa and Tnfsf10 = Trail) and the
insulin-like growth factor (IGF) inhibitor Igfbp5. (e) Differentially
expressed receptors and ligands involved in recognition and
engulfment of apoptotic cells. Y axes indicate the normalized intensity.
(Note that the brackets in panel d represent scale for Igfbp5 only.)
X axes indicate developmental time points for the complete 12-point
time course (panels a, b and c) and 7-point lactation/involution time
course (d, e).
ment components are prevalent at all stages during involu-
tion (Table 3). These factors are found at high levels in
mastitic milk and in normal bovine mammary glands during
involution, and are thought to play a dual role in opsoniza-
tion and lysis of bacteria and as a proinflammatory mediator
[39,40]. Cd14 was significantly upregulated in involution
and was also highly expressed during parturition (Fig.6c).
This antigen is expressed on bovine mammary polymor-
phonuclear neutrophils and macrophages [41] and plays
an integral role in suppressing bacterial infections in
response to endotoxin. Furthermore, Lbp [42] and Ly86
[43], which in conjunction with Cd14 augment responses
to lipopolysaccharide (LPS), were also upregulated. The
significant regulation of these genes in uninfected
mammary gland confirms a role for soluble defence factors
in normal development of mouse mammary gland.
Involution is associated with a transient induction of
death receptor genes
Involution is characterized by extensive apoptosis of
epithelial cells, which occurs both before and during the
tissue remodelling process. By subdividing the first 4 days
of involution into three discrete phases of gene expres-
sion, we demonstrated a link between the expression of
apoptosis-related genes and the delayed onset of extra-
cellular matrix degradation and alveolar collapse at
48 hours (Inv3 and Inv4; Table 2). However, we were
unable to identify a significant increase in the number of
apoptosis genes expressed at the onset of involution. One
explanation for this was that specific combinations of cell
death genes, rather than an increase in the number of
genes activated, influenced apoptosis at the onset of invo-
lution. In order to address this, all cell death related genes
found to be regulated during involution were grouped
according to their lactation/involution expression pattern
(Table 4). Regulators (Bax, BclX, Mcl1, mXIAP and
Apaf-1) and effectors (caspases) of classical apoptosis
and immune cell-mediated killing (granzyme A, granzyme B,
Fadd, Fas, Fas ligand) were regulated with different kinet-
ics during involution and were relatively evenly distributed
across the four involution clusters (Table 4).
However, we observed a strong bias in the expression of
extrinsic (death receptor) and intrinsic (mitochondrial)
apoptosis genes, in which extrinsic-related components
were generally induced within the first 24 hours of involu-
tion whereas intrinsic genes, with the exception of Hrk and
Diva, were not maximally transcribed until at least 96 hours.
Thus, six ligands of the TNF superfamily (Tnf, Tnfsf4,
Tnfsf6, Tnfsf7, Tnfsf10 and Tnfsf12) were specifically
induced in involution and all were transiently activated at
12 hours after weaning (Inv1; Fig. 6d). Four of these
ligands (death receptor ligands: Fas ligand, TNF-α,
TWEAK and TRAIL) are responsible for activating the five
principal mammalian death receptor (extrinsic) apoptosis
pathways through their cognate receptors Fas, TNFR-1,
TNFR-2, DR3 and DR4. Two of these receptors (Fas and
Tnfrsf1a) were also induced, and maximally coexpressed,
within 24 hours of weaning (Inv3; Table 4). This correlates
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Table 4
Cell death-related genes in lactation and involution clusters
Inv1 Inv2 Inv3 Inv4 Lac 1 Lac2 Lac3
Cell survival Prdx2 Nfkb2 Api5 Bcl2l (BclX) Psap Akt1
Bcl10 Ank3 Mcl1 Birc4(mXIAP) Dad1
Psap Gfi1
Cell death Hrk Bcl2l10 (Diva) Fsp27 Igfbp5 Tnip1 (ABIN1) Tnfrsf11a(Rank)
Gzmb Casp4 (casp11) Bax Casp1 Eya2 Cidea
Nkx3-1 Casp12 Casp7 Foxm1 Tial1 Dffb
Tnfsf6(FasL) Gadd45b Serpinb5 Apaf1 Dapk3 Perp-pending
Lsp1 Pdcd6 Pdcd6 Gzma Foxb1 Traf6
Tnfsf4(OX40L) Cdkn1a (p21) Pdcd5 Tia1 Rbl2 Tnfsf9
Tnfsf7 (Cd27l) Unc5 Tnfrsf6 (Fas) Phlda1 Tnfsf5 (TRAP)
Tnfsf10 (Trail) Foxb2 Fadd Tnfrsf4 (Ox40)
Tnfsf12 (Tweak) Mycs (s-myc) Myd88 Tgfb1
Tnfrsf9 (Cd137) E4bp4 Tnfrsf1a
Tnf (Tnfa) Ngfa
Ltbr
The identity of cell death-related transcripts was determined for each of the profile clusters illustrated in Fig. 4. Thus, transcripts belonging to the
ontological category apoptosis or cell death from each cluster were listed according to their expected role as proapoptotic or survival factors. All
gene names conform to the mouse genome informatics database [23], and synonyms are included in brackets where appropriate. A complete
genelists for this apoptosis category is available on GeNet (see Method section). 
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with previous studies in mammary gland of two of these
ligand–receptor pairs [44,45]. NF-κB activity also corre-
lated with the rapid activation of these TNF superfamily
ligands. DNA binding activity of this transcription factor is
markedly upregulated within 3 hours of forced involution
and is suggested to promote survival of a subpopulation of
mammary epithelial cells [26]. Thus Nfkb2 and activators
of NF-κB (Tnfsf12, Bcl10, Tnfrsf11a, Traf6 and Tnfsf10)
were upregulated, whereas an inhibitor of NF-κB function
(Tnip1) was inhibited during the initial 24 hours following
forced weaning, when NF-κB activity was induced [26].
Previous studies demonstrating the direct activation of
NF-κB by TNF superfamily ligands in mammary epithelial
cells [26,46,47] therefore suggests that the observed tran-
sient increase in these ligands may be functionally relevant.
In contrast to the rapid response of extrinsic factors, intrin-
sic apoptosis genes were predominantly (but not exclu-
sively) expressed at least 24 hours after forced weaning.
Proapoptotic and antiapoptotic members of the Bcl-2
family (Bax, Mcl1 and Bcl2l) were induced together with
the downstream effector of the intrinsic pathway Apaf1.
Although the precise mechanism(s) of cell death in
mammary gland have yet to be established, the trends in
apoptosis gene expression identified here hint that extrin-
sic (death receptor) and intrinsic death programmes may
predominate at different times. A marked induction of
Igfbp5 complemented the delayed induction of intrinsic
apoptosis genes (Fig. 6d). The kinetics of this potent
inducer of mammary apoptosis and involution [48] sug-
gests that it probably contributes to the stimulation of
intrinsic cell death at this time.
Apoptotic bodies initially shed into the lumen and the
residual dying cells left in the epithelium are believed to be
cleared from the mammary gland by nonprofessional
phagocytes and interstitial macrophages, respectively
[28]. Receptors and ligands that mediate recognition and
engulfment of apoptotic cells include members that are
common to both types of phagocytic cell (e.g. Cd36, Lrp1
and Mfge8) and those specific to professional
macrophages (e.g. Cd14 and Cd68). The genes for each
of these factors (except Cd36, which exhibits an initial
downregulation before a modest increase by 96 hours)
are induced with similar kinetics (Fig. 6e). This is indicative
of the increasing demands placed on the mammary gland
to clear dead/dying cells during regression, and also prob-
ably reflects the increasing numbers of macrophages
occupying the gland during the first 4 days of involution.
Discussion
Microarray analysis of large sequence verified cDNA
probe sets provides a powerful tool for analyzing complex
biological systems because it can extract patterns of gene
expression from a significant proportion of the total
genomic content of an organism. In this study we simulta-
neously analyzed approximately 12 000 transcripts, repre-
senting 8618 unigene clusters, or about one-third of the
protein encoding capacity of the mouse, to determine
basic expression patterns in adult mammary gland during
the pregnancy cycle.
Although a previous study of approximately 5000 tran-
scripts described gene expression in early phases of the
pregnancy cycle [14], we focused our analysis on the first
4 days after forced weaning, using time points from earlier
stages in development to establish the specificity of these
involution-related genetic changes. In the accompanying
paper, Stein and coworkers [19] describe a similar study
in Balb/c animals. Despite differences in the methods of
analysis, their findings on the activation of inflammatory
mediators and monocyte/lymphocyte markers in involution
correlate with the results described here, further verifying
our microarray data. Thus, strain differences did not appre-
ciably influence the immune responses associated with
involution.
The principal objective of the present study was to provide
a comprehensive set of gene expression data from late
stages of mouse mammary development to be used as an
online resource for further analysis and/or download. The
raw microarray data files and processed genelists from the
study are therefore available for download or online analy-
sis (see www.path.cam.ac.uk/~madgroup/).
Here we have outlined the common patterns of gene
expression across the developmental time course and
have correlated these patterns with biological function.
Thus, as expected, pregnancy was associated with the
induction of genes that are involved in cell proliferation,
differentiation and tissue morphogenesis. This was
superceded in lactation by genes involved in biosynthetic
(fatty acid synthesis) and metabolic pathways, correlating
with the findings of an earlier microarray study of the preg-
nancy cycle [14]. We have not attempted to provide a
detailed account of the genetic changes that occur early
in the pregnancy cycle; however, the data are available
online for further scrutiny.
By concentrating six of our 12 time points around the first
96 hours of involution, we were able to determine the
general kinetics of gene expression during this period.
Thus, according to the cluster analysis presented in Fig. 4,
most differentially expressed transcripts in involution were
initially induced (or suppressed) within 24 hours of
weaning, whereas maximum expression generally
occurred at 12 (Inv1, Inv2), 48 (Inv3) or 96 (Inv4) hours.
This implies three phases of gene expression in the first
4 days of involution – phases that are characterized both
by their time of initiation and their rate of induction. At the
cellular level this period of involution has previously been
divided into two stages [2]: an initial reversible period of
approximately 48 hours characterized by increased apop-
tosis and loss of differentiated function, followed by matrix
degradation and alveolar collapse. The pattern of gene
expression appeared to correlate with this cellular model.
We observed a swift increase in specific apoptosis tran-
scripts (Inv1; Table 4) and a subsequent decline in differen-
tiated function by 48 hours (Inv3; Table 2), followed by an
increase in factors affecting tissue architecture (Inv4;
Table 2) and phagocyte function (Fig.6). Further detailed
analysis of the Inv3 cluster, which exhibits maximal expres-
sion at 48 hours, may elucidate underlying mechanisms that
are responsible for the transition to phase two involution.
Transcriptional regulation of apoptosis in involution:
two phases of death?
Our data also provide provisional evidence for the exis-
tence of a two-phase apoptotic process in involution and
which also coincides with the two phases previously
described [2]. While the number of apoptosis genes was
similar in each involution cluster, there was a pronounced
bias in the distribution of extrinsic and intrinsic apoptosis
genes. The initial spike of activity consisted of four death
receptor ligands, namely Tnf (TNF-α) Tnfsf6 (Fas ligand),
Tnfsf10 (TRAIL) and Tnfsf12 (TWEAK). These ligands
bind to the principal death receptors Fas, TNFR-1,
TNFR-2, DR3 and DR4, which initiate apoptosis in cell
mediated immune cell death and in a variety of physiologi-
cal and pathological situations. These data confirm previ-
ous observations that Fas and Fas ligand are upregulated
within a day of involution in mouse mammary gland, and
that the deletion of these genes results in delayed regres-
sion and loss of apoptosis [44]. Deregulation of Fas sig-
nalling through aberrant Akt and NF-κB activity is believed
to play a role in the immune escape of breast cancers and
in resistance to chemotherapy [49]. TNF-α also induces
NF-κB signalling to prevent apoptosis in a subpopulation
of cultured mammary epithelial cells [26,47], and has been
shown to be downregulated late in involution (day 7);
however, it has not been studied at earlier time points
[50]. Furthermore, elevated IL-10 dependent TRAIL
expression (and its receptor DR4) has previously been
demonstrated in involution [45].
In contrast to the transient activation of death receptor
ligands, components of mitochondrial (or intrinsic) apopto-
sis exhibit sustained, often delayed induction. Thus the
caspase 9 effector, Apaf1, and Bax were induced with
delayed kinetics. Costimulation of the survival factors Mcl1
and Bcl2l (BclXl) suggests that the transcriptional regula-
tion of Bax may be counterbalanced, and therefore con-
trolled, by expression of Bcl-2 homologues. Suppression
of BclX, for example, promotes death during mammary
involution [51], whereas delayed induction of Bax has pre-
viously been demonstrated [52]. Regulation of Bcl homo-
logues was not exclusively restricted to late stage
involution. Hrk and Boo/Diva were differentially expressed
within 24 hours. Hrk is a proapoptotic factor that is tran-
scriptionally suppressed by progesterone signals in breast
cancer cell lines [53]. The function of Boo/Diva, which has
only previously been described in mouse ovary, is poorly
defined [54]. Cross-talk between death receptor pathways
and Bcl-2 regulatory factors is well established [55] and
may explain the early activation of these two Bcl homo-
logues. Probable upstream initiators of a putative delayed
apoptotic mechanism include the loss of survival signals,
such as insulin-like growth factor (IGF)-1 [48,56], and the
destruction of extracellular matrix–integrin contacts
leading to an anoikis-type death [6,57]. The dramatic
induction of the proapoptotic mammary protein IGF-
binding protein 5 proposed previously [48] coincides with
the onset of second phase involution (Fig. 6d, Table 4) and
the upregulation of metalloproteinases [2,6]. Both IGF-1
and integrins signal through Akt, which was also downreg-
ulated in involution (Table 4). Loss of this signal could then
induce Bax [57]. Our data suggest that apoptosis is
induced in involution following the specific transcriptional
activation of a subset of proapoptotic genes encoding
death receptors, and that delayed expression of inhibitors
of cell survival (e.g. IGF-binding protein 5) induce alternate
apoptosis pathways during the second phase of involu-
tion. This hypothesis warrants further investigation.
Integral to the apoptotic process is the phagocytic clear-
ance of apoptotic bodies by macrophages. It has been sug-
gested that monocytic macrophages are recruited to the
mammary gland to supercede phagocytic epithelial cells in
the clearance of milk and dead cells [28]. We have demon-
strated monocyte specific (Cd14 and Cd68) and nonspe-
cific phagocyte receptors during involution, supporting a
role for monocytic phagocytes in mammary involution.
Multiple roles for immune cells in mammary involution
Measurements of the cellular content in milk from involut-
ing glands of sheep, pigs and cattle indicate an early rise
in polymorphonuclear neutrophils, a subsequent increase
in macrophages and low numbers of eosinophils, B cells
and T cells [7,28]. However, the immune cell complement
of human and rodent mammary gland is poorly defined. It
is believed that these phagocytes are recruited to the
gland to perform several functions in phagocytic clearance
and cellular immunity.
We have described the sequential activation of cytokine
and chemokine genes in involution. The effect of these
would be to attract monocytes and lymphocytes to the
gland, and we identified an increase in a number of
immune cell markers, supporting this hypothesis. For
example, increased expression of the Csf-1 receptor,
c-fms (Csf1r; Fig. 6a), which is restricted to macrophages
of the monocyte lineage in mammary gland [58] and is
required for appropriate branching morphogenesis in
pregnancy [59], confirmed that macrophages are critical
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for normal development [58]. A role for these cells in
phagocytic clearance during involution is emphasized by
the concomitant increase in two receptors (Cd14 and
Cd91) and the milk factor Mgfe8, which mediate recogni-
tion of apoptotic cells by macrophages (Fig. 6c,e).
Recruitment of cells of the monocytic lineage comprises
an inflammatory response. However, in the absence of a
persistent bacterial infection, this does not occur in the
regressing mammary gland, even though inflammatory
cytokines and downstream mediators are activated, pre-
sumably to perform additional roles during involution.
During chronic inflammatory diseases such as rheumatoid
arthritis or inflammatory bowel disease, uncontrolled accu-
mulation of neutrophils yield aberrantly elevated levels of
inflammatory compounds, which become major contribu-
tors to tissue damage [60,61] Thus, regulation of neu-
trophil recruitment into inflammatory sites and their
clearance are critical processes that ensure effective host
defence without tissue injury. In mammary gland, the
LIF–Stat3 signaling pathway is known to be crucial for
appropriate regression during early involution by initiating
epithelial apoptosis [17,24]. With the concomitant down-
regulation of IL-11 receptor (Table 3) and lack of a signifi-
cant increase in IL-6 or its receptor (data not shown), it is
also likely to be the predominant protagonist of acute
phase signalling. This is confirmed by previous observa-
tions that C/ebpβ and C/ebpδ are both transcriptional
targets of Stat3 in vivo [24] (Boland M, unpublished data)
and that the profiles of Class I acute phase genes corre-
lated precisely with phosphorylated Stat3 activity [24] and
Stat3, C/ebpβ and C/ebpδ expression (Fig. 3). Class II
acute-phase response genes exhibit specific and transient
expression in involution. It is thought that these genes
respond transiently to proinflammatory signals [25] and
therefore may respond in a similar manner to the rapid
activation of Stat3 at the onset of involution. Why they are
not induced at parturition is unclear, although a molecular
switch that determines the specificity of signalling path-
ways downstream of LIF has been proposed [24].
Thus, inhibitory mechanism(s) must exist to prevent the
accumulation of potentially damaging cellular infiltrates in
response to LIF. In a previous study of involution in uterus
and mammary gland, the acute phase protein uterocalin
(Lcn2) was shown to be induced [29]. It was proposed
that one role of this protein in involuting mammary gland
and uterus was to eliminate infiltrating neutrophils by
inducing apoptosis [62] and therefore to prevent subse-
quent tissue damage [63]. We are able to confirm signifi-
cant activation of uterocalin expression in mammary
involution (Fig. 6b) and the concomitant absence of neu-
trophil antigens (Table 3). In conjunction with the induction
of uterocalin, clusterin (Sgp2), oncostatin M receptor
(Osmr) and secretory leukocyte inhibitory protein (Slpi)
were also increased (Fig. 6b). Clusterin protects cells
against oxidative and chemical damage [33,34] and has
been suggested to be coexpressed with uterocalin as part
of a localized acute-phase response in order to limit the
damaging effects of residual neutrophils in involuting
mammary gland [29,63]. SLPi, an antichymotrypsin, also
contributes to the elimination of neutrophil function,
whereas Osmr may possess similar anti-inflammatory
effects through the sequestration of proinflammatory
cytokines. Osmr, Slpi and Sgp2 are all directly induced by
Stat3 in mammary epithelial cells (Boland M, unpublished
data) [64], whereas uterocalin expression conformed with
Stat3 activity (Fig. 3 and 6b). A putative anti-inflammatory
role for Stat3 was suggested in our previous study of
Stat3-deficient mammary glands [17], in which we
observed an increase in mastitis in the absence of Stat3.
A similar protective mechanism may exist during parturi-
tion, when the LIF–Stat3 signal is also active [24,65]. We
are currently investigating the possibility that LIF–Stat3
signalling is responsible for the induction of these four
genes in mammary gland, therefore confirming a dual role
for LIF in involuting mammary gland. In addition to the
direct effects of these anti-inflammatory acute phase
genes, immunosuppressive factors including transforming
growth factor-β (Inv3; Table 3) expressed by phagocytic
macrophages are likely also to contribute to the suppres-
sion of an inflammatory response [64,66].
Soluble defence factors are induced during involution
Soluble defence factors and cells that are involved in
humoral immunity are thought to be induced to prevent
mastitis during this extended period of milk stasis. For
example, the iron chelator lactoferrin is induced in
mammary involution (Fig. 6c), which plays a role in
mammary defence by protecting against coliform infection
[36]. Indeed, low levels of lactoferrin is a predisposing
factor for mastitis in humans [38]. Immunoglobulins not
only have an important role in supplementing milk but are
also required to facilitate opsonization by macrophages
and neutrophils (IgM and IgG2) [67] and the direct
sequestration of bacteria (IgA).
Cd14 exhibited a dramatic pattern of expression through-
out the complete time course (Fig. 6c). Cd14 is a core
component of innate immunity, which binds LPS and aug-
ments LPS responses [42]. It is found bound to intramam-
mary monocytes or neutrophils [41] in cattle subjected to
endotoxin, and its soluble form is a known constituent of
milk, in which it helps Cd14-negative cells respond to
infection [68] and contributes to inhibition of gastrointesti-
nal infections in human infants [69]. It may also play a role
in recognition and phagocytosis of apoptotic cells by
macrophages expressing cell surface Cd14 [70]. Thus,
the role of elevated Cd14 may be both to prevent infection
and potentiate apoptotic cell clearance. Binding of soluble
Cd14 to LPS is augmented by the acute phase protein
Lbp, which also exhibited an IP expression profile (Fig. 6c).
Conclusion
We highlighted two general trends in gene expression
during mouse mammary involution: an increase in immune-
related genes and a shift in the identity of apoptosis com-
ponents. The increase in immune genes correlated with
previously described roles for immune cells in involuting
mammary gland, namely antimicrobial defence, cytokine
signalling and phagocytic clearance. The proposed
change in the cell death machinery based on extrinsic and
intrinsic apoptosis gene expression has not previously
been observed. This putative mechanism clearly needs
further investigation. One common link between apoptosis
and immune responses in mammary gland is the previ-
ously defined role for LIF and Stat3. We are currently
investigating the possibility that Stat3 mediates the anti-
inflammatory effects vital for the protection of the
mammary gland in addition to its recognized role as a
proapoptotic factor in mammary gland.
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